4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-027206
Options or other derivatives
- CEO acquired 385,067 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-05-01 | Grant or award · Stock Options (Right to Buy) | +295,503 | 295,503 | D | ||
| DAVIS STEPHEN CEO | 2023-05-01 | Grant or award · Restricted Stock Units | +89,564 | 89,564 | D | ||
Loading xslF345X04/doc4.xml…